Clay Thorp - 06 Jan 2022 Form 3 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Director
Signature
/s/ Jennifer Ziolkowski, Attorney-in-Fact
Issuer symbol
VIGL
Transactions as of
06 Jan 2022
Net transactions value
$0
Form type
3
Filing time
06 Jan 2022, 19:34:40 UTC
Previous filing
18 Aug 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VIGL Series A Preferred Stock 06 Jan 2022 Common Stock 920,243 By Hatteras Venture Partners VI, L.P. F1, F2
holding VIGL Series B Preferred Stock 06 Jan 2022 Common Stock 334,092 By Hatteras Venture Partners VI, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") are convertible into Common Stock on a one-for-2.7732 basis at the option of the holder, and will automatically convert into the number of shares shown in Column 3 immediately prior to the closing of the Issuer's initial public offering. The Preferred Stock has no expiration date.
F2 The shares are held directly by Hatteras Venture Partners VI, L.P. ("Hatteras VI"). Hatteras Venture Advisors VI, LLC ("HVA VI") is the general partner of Hatteras VI. The Reporting Person is a managing member of HVA VI and disclaims beneficial ownership of the shares held by Hatteras VI except to the extent of his pecuniary interest therein, if any.

Remarks:

Exhibit 24 - Power of Attorney